 | Eagle Pharmaceuticals, Inc. | |||
| NGM : EGRX || Location: United States | ||||
$4.61+0.13 (+2.9%) |
0.06 M | 4.48 - 4.74 | ||
| Last Updated:America/New_York | Volume | Day range |
Total Call Open Interest - | Total Put Open Interest -
Today's Total Call volume - | Total Put volume -
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 1.209 M |
| March 15, 2024 | 1.163 M |
| Feb. 29, 2024 | 1.113 M |
| Feb. 15, 2024 | 1.063 M |
| Jan. 31, 2024 | 0.796 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 06/30/2023 | 1.07 | 1.18 | 10.18% |
| 03/31/2023 | 1.07 | 1.26 | 17.65% |
| 12/31/2022 | 0.85 | 1.10 | 29.93% |
| 09/30/2022 | 0.92 | 1.12 | 21.11% |
| 06/30/2022 | 3.36 | 1.56 | -53.60% |
EGRX Basic Data
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Shares Outstanding | 12.958M | Shares Float | 10.385M |
| Short Float | 1.209M | Market Cap | 59.74M |
| Institution ownership | 87.17% | Insider ownership | 12.023% |
| Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
| Trailing EPS | 0.82 | Forward EPS | 3.48 |